SCI | ||
---|---|---|
OUTLOOK RATING 1..100 | 75 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 54 Fair valued | |
PROFIT vs RISK RATING 1..100 | 16 | |
SMR RATING 1..100 | 29 | |
PRICE GROWTH RATING 1..100 | 54 | |
P/E GROWTH RATING 1..100 | 47 | |
SEASONALITY SCORE 1..100 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SCI | SMI | |
---|---|---|
RSI ODDS (%) | 1 day ago73% | N/A |
Stochastic ODDS (%) | 1 day ago55% | 1 day ago40% |
Momentum ODDS (%) | 1 day ago51% | N/A |
MACD ODDS (%) | 1 day ago50% | 1 day ago44% |
TrendWeek ODDS (%) | 1 day ago48% | 1 day ago39% |
TrendMonth ODDS (%) | 1 day ago55% | 1 day ago38% |
Advances ODDS (%) | 11 days ago57% | N/A |
Declines ODDS (%) | 1 day ago48% | N/A |
BollingerBands ODDS (%) | 1 day ago63% | N/A |
Aroon ODDS (%) | 1 day ago33% | N/A |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FCHKX | 43.30 | 0.44 | +1.03% |
Fidelity Advisor China Region C | |||
EIMGX | 32.64 | 0.30 | +0.93% |
Eaton Vance Tx-Mgd Small-Cap I | |||
GSVRX | 15.66 | 0.08 | +0.51% |
Goldman Sachs Large Cap Value R | |||
VTSNX | 148.72 | 0.74 | +0.50% |
Vanguard Total Intl Stock Index I | |||
JFNSX | 62.89 | -0.39 | -0.62% |
Janus Henderson Global Life Sciences S |
A.I.dvisor indicates that over the last year, SCI has been loosely correlated with CSV. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SCI jumps, then CSV could also see price increases.